- Published on: December 30, 2021
- 12:07
Moscow, Dec 30 (Prensa Latina) The Russian state corporation Rostec reported this Thursday that its new drug COVID-Globulin, against the SARS-CoV-2 coronavirus, successfully passed clinical trials and received a certificate of permanent registration from the Health Ministry.